GlassScriptPhysician profile
Margaret Apedo
NPI 1831240886
$969.09
in general payments reported to CMS, 2019-2025
18 companies · none reported in 2025
See the full distribution for Endocrinology, Diabetes & Metabolism
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $155 · 2020: $536 · 2021: $217 · 2022: $61.15.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $225.73 | 2020-2022 | |
| Janssen Pharmaceuticals, INC | $155.65 | 2019-2020 | |
| Glaxosmithkline, LLC. | $85.94 | 2020-2021 | |
| Astrazeneca Pharmaceuticals LP | $78.91 | 2020-2021 | |
| Lilly USA, LLC | $72.88 | 2020-2021 | |
| Merck Sharp & Dohme LLC | $68.90 | 2020-2021 | |
| Abbott Laboratories | $47.32 | 2019-2022 | |
| Arbor Pharmaceuticals, INC. | $32.28 | 2020 | |
| Medtronic Minimed, INC. | $32.12 | 2020 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $31.36 | 2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $24.14 | 2021 | |
| Abbvie INC. | $22.76 | 2020 | |
| Sanofi-Aventis U.S. LLC | $22.67 | 2020 | |
| Endo Pharmaceuticals INC. | $20.83 | 2020 | |
| Amgen INC. | $15.38 | 2020 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Antares Pharma, INC. | $14.54 | 2021 | |
| Clarus Therapeutics INC. | $10.02 | 2021 | |
| Currax Pharmaceuticals LLC | $7.66 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Margaret Apedo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.